Tissue resecting system

Information

  • Patent Grant
  • 10076237
  • Patent Number
    10,076,237
  • Date Filed
    Monday, April 11, 2016
    8 years ago
  • Date Issued
    Tuesday, September 18, 2018
    6 years ago
Abstract
A surgical system includes a first instrument defining a first channel and a second instrument receivable by the first channel. The second instrument defines a second channel. A valve coupled to the first instrument controls fluid flow through the first channel, such that impedance of fluid flow through the first channel is substantially the same without the second instrument received in the first channel and with the first channel partially blocked by the second instrument. In another aspect, a surgical apparatus includes an outer member and an inner member received within the outer member to define a first channel therebetween. The inner member houses an optical lens and defines a second channel for receiving a surgical instrument. The first and second channels are configured such that a pump having an inflow rate of up to about 0.7 L/min connected to the second channel can maintain fluid pressure inside an organ.
Description
TECHNICAL FIELD

This invention relates to a tissue resecting system.


BACKGROUND

Endoscopic surgery of a distensible organ, such as a uterus, may be performed with an endoscope that is insertable into the uterus and a resector that passes through the endoscope to cut or otherwise treat tissue in the uterus. During surgery, it often is desirable to distend the uterus with a fluid, such as saline, sorbitol, or glycine, in order provide a visible working space. Fluid can be infused into the uterus and removed from the uterus through the endoscope and/or resector.


SUMMARY

If the outflow of fluid from the uterus is greater than the inflow of fluid to the uterus, the uterus may collapse back to its normal state, making visualization of the uterus difficult. On the other hand, if the inflow of fluid is greater than the outflow of fluid such that the pressure created by the fluid is greater than the patient's mean arterial pressure, excess fluid can enter the patient's vascular system (known as intravasation), which can lead to serious complications or death.


To aid in addressing these issues, in an aspect of the invention, a surgical system includes a first instrument defining a fluid flow channel and a second instrument receivable by the first instrument fluid flow channel. The second instrument defines a channel. The system includes a valve coupled to the first instrument and configured to control fluid flow through the first instrument channel. The valve is configured such that impedance of fluid flow through the first instrument channel is substantially the same without the second instrument received in the first instrument channel and with the first instrument channel partially blocked by the second instrument such that the first instrument channel is limited to a region between the first and second instruments.


Embodiments of this aspect of the invention may include one or more of the following features.


For example, the first instrument includes an outer member and an inner member. The inner member defines the first instrument channel therethrough. The inner member is received within the outer member, and the outer member and the inner member define a second fluid flow channel therebetween. The second instrument includes a tube defining the second instrument channel therethrough. The tube partially blocks the first instrument fluid flow channel when received therein. The second fluid flow channel has a cross-sectional area of, e.g., about 0.0083 to about 0.0249 square inches, preferably about 0.0166 square inches. The first instrument fluid flow channel has a cross-sectional area of, e.g., about 0.0053 to about 0.0159 square inches, preferably about 0.0106 square inches. The second instrument channel has a cross-sectional area of, e.g., about 0.0042 to about 0.013 square inches, preferably about 0.0085 square inches.


In an illustrated embodiment, the valve includes a housing and a body within the housing. The body defines an opening therein and is moveable relative to the housing between a first position in which the opening and the first instrument channel define a first fluid flow path having a first impedance and a second position in which the opening is arranged to receive the second instrument therethrough such that the opening and the first instrument channel define a second fluid flow path that has a second impedance substantially equal to the first impedance.


The system as illustrated includes a pump and the first instrument is configured to connect to the pump such that the pump infuses fluid through the first instrument channel. The pump is programmed to infuse fluid through the first instrument channel to maintain a substantially constant pressure of between about 60 mm Hg and about 120 mm Hg inside a distensible organ. A sensor coupled to the pump senses a flow impedance at a given flow rate, and a controller coupled to the sensor and the pump compares the flow impedance to a predetermined flow impedance for the given flow rate to verify the identity of the first and second instruments.


The second instrument channel is in fluid communication with a source of suction and a regulator is interposed between the second instrument channel and the source of suction to regulate an amount of suction applied through the second instrument channel.


According to another aspect of the invention, a surgical system includes a first instrument defining a fluid flow channel, and a second instrument receivable by the first instrument fluid flow channel. The second instrument defines a channel. The system includes a means for maintaining a substantially constant impedance of fluid flow through the first instrument channel with and without the second instrument received in the first instrument channel.


According to another aspect of the invention, a method includes: (a) positioning a valve coupled to a first instrument in a first position; (b) introducing fluid to a distensible organ through the valve with the valve in the first position and through a channel in the first instrument; (c) positioning the valve in a second position; (d) introducing a second instrument through the valve with the valve in the second position and through the first instrument channel; and (e) introducing fluid to the distensible organ through the valve with the valve in the second position and through a region of the first instrument channel located between the first and second instruments. The impedance of fluid flow in steps (b) and (e) is substantially the same.


Embodiments of this aspect may include one or more of the following features. The method includes maintaining substantially constant fluid pressure within the distensible organ with and without the second instrument received in the first instrument channel. Maintaining includes suctioning fluid from the distensible organ through the second instrument. The method includes regulating a pump coupled to the valve for introducing fluid through the valve.


According to another aspect of the invention, a valve includes a housing and a body within the housing. The body defines an opening therein. The body is moveable relative to the housing between a first position in which the opening and the housing define a first fluid flow path having a first impedance and a second position in which the opening is arranged to receive a surgical instrument therein. The opening is configured such that with the surgical instrument received therein, the opening and the housing define a second fluid flow path that has a second impedance substantially equal to the first impedance.


Embodiments of this aspect may include one or more of the following features. The opening includes a throughbore through the body for receiving the surgical instrument. The opening includes a second bore having a first open end and a second closed end in the body. The second bore is arranged substantially orthogonal to the throughbore and intersects the throughbore. The housing defines an inlet and an outlet. When the body is in the first position, the throughbore is partially aligned with the inlet and the first fluid flow path is from the inlet, through the throughbore, and then through the second bore to the outlet. When the body is in the second position, the second bore is aligned with the inlet and the second fluid flow path is from the inlet, through the second bore, and then through the throughbore to the outlet.


According to another aspect of the invention, a method of regulating inflow through a valve includes positioning the valve in a first position wherein the valve has a first impedance; positioning the valve in a second position; and introducing a surgical instrument through the valve in the second position. A combination of the surgical instrument and the valve has a second impedance substantially equal to the first impedance.


According to another aspect of the invention, an apparatus for surgery includes an outer member and an inner member received within the outer member. The outer member and the inner member define a first channel therebetween. The inner member houses an optical lens and defines a second channel for receiving a surgical instrument. The first and second channels are configured such that a pump having an inflow rate of up to about 0.7 L/min connected to the second channel can maintain fluid pressure inside an organ.


Embodiments of this aspect may include one or more of the following features. A pump is coupled to the second channel to introduce fluid through the second channel at an inflow rate up to about 0.7 L/min. The outer member defines a plurality of holes in fluid communication with the first channel. The plurality of holes is positioned in a distal portion of the outer member. The second channel has a D-shaped cross-section. The first channel has a cross-sectional area, e.g., of about 0.0083 to about 0.0249 square inches, preferably about 0.0166 square inches. The second channel has a cross-sectional area of, e.g., about 0.0053 to about 0.0159 square inches, preferably about 0.0106 square inches. The second channel receives the surgical instrument. The surgical instrument has a suction channel with a cross-sectional area of, e.g., about 0.0042 to about 0.013 square inches, preferably about 0.0085 square inches. A valve is coupled to the inner member for regulating inflow through the second channel such that the valve and the second channel have a first impedance equal to a second impedance when the surgical instrument is received in the second channel.


According to another aspect of the invention, a fluid management system includes a pump configured for coupling to an endoscope to infuse fluid through the endoscope at a given flow rate. A sensor is coupled to the pump that senses a flow impedance through the endoscope at the given flow rate. A controller is coupled to the sensor and programmed to compare the flow impedance to a predetermined flow impedance for the given flow rate to verify the identity of the endoscope and a surgical instrument received therein.


Embodiments of this aspect may include one or more of the following features. The sensor includes a pressure transducer. A circuit is coupled to the controller and the pump for disabling the pump if the identity of the surgical instrument and endoscope is not verified. The controller is programmed to compare flow impedances to predetermined flow impedances at multiple flow rates.


According to another aspect of the invention, a fluid management system includes means for infusing fluid through an endoscope at a flow rate, means for measuring a flow impedance through the endoscope at the flow rate, and means for comparing the flow impedance to a predetermined flow impedance to verify the identity of the endoscope and a surgical instrument received therein.


According to another aspect of the invention, a method includes programming a pump with data on a predetermined flow impedance for an endoscope and surgical instrument assembly for a given flow rate, activating the pump to infuse fluid through the endoscope and surgical instrument assembly at the given flow rate, sensing a flow impedance through the assembly, and comparing the sensed flow impedance to the predetermined flow impedance. The method may further include disabling the pump if the flow impedance is not within a threshold value of the predetermined flow impedance.


According to another aspect of the invention, a method includes infusing fluid into a distensible organ, and maintaining a substantially constant fluid pressure inside the distensible organ between about 60 mm Hg and about 120 mm Hg.


According to another aspect of the invention, a system includes an endoscope defining a channel therethrough and a surgical instrument received within the endoscope channel. The surgical instrument defines a channel therein for connection with a source of suction. A regulator is coupled to the surgical instrument channel between the instrument channel and the source of suction to regulate an amount of suction applied through the instrument channel.


The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.





DESCRIPTION OF DRAWINGS


FIG. 1 is a schematic diagram of a resection system.



FIG. 2A is an exploded, perspective view of a hysteroscope of the system of FIG. 1.



FIG. 2B is a perspective view of the assembled hysteroscope of FIG. 2A.



FIG. 3A is a longitudinal cross-sectional view of the hysteroscope of FIG. 2B.



FIG. 3B is a cross-sectional view of the hysteroscope of FIG. 2B taken along line 3B-3B.



FIG. 4 is a perspective view of the hysteroscope of FIG. 2B with a resector received therethrough.



FIG. 5 is a cross-sectional view of the hysteroscope and resector of FIG. 4 taken along line 5-5.



FIG. 6A is a perspective cut-away view of primary and secondary valves of the hysteroscope of FIG. 2B, with the primary valve in an open position and the secondary valve in a first position.



FIG. 6B is a cross-sectional view of the primary and secondary valves as shown in FIG. 6A taken along line 6B-6B.



FIG. 7A is a perspective cut-away view of the primary and secondary valves of the hysteroscope of FIG. 2B, with the primary valve in an open position and the secondary valve in a second position for receiving the resector.



FIG. 7B is a cross-sectional view of the primary and secondary valves as shown in FIG. 7A taken along line 7B-7B.



FIG. 8A is a perspective cut-away view of the primary and secondary valves of the hysteroscope of FIG. 2B, with the primary valve closed and the secondary valve in the second position.



FIG. 8B is a cross-sectional view of the primary and secondary valves as shown in FIG. 8A taken along line 8B-8B.



FIG. 9 is a schematic diagram of a fluid management system of the resection system of FIG. 1.



FIG. 10 is a perspective view of an obturator for use with a sheath of the hysteroscope of FIG. 2A.



FIGS. 11-13 show the obturator, hysteroscope and resector in use.



FIG. 14 is a graph showing the impedance through the hysteroscope at various flow rates.





DETAILED DESCRIPTION

Referring to FIG. 1, a tissue resecting system 10 includes an endoscope, e.g., hysteroscope 100, having a distal portion 102 insertable into a distensible organ, e.g., a uterus, of a patient 20 to flow fluid into and remove fluid from the organ. System 10 includes a cart carrying fluid bags 17 that are connected to hysteroscope 100 by an inflow line 30 to deliver fluid to hysteroscope 100. Inflow line 30 runs through a pump, e.g., peristaltic pump 310, of a fluid management control unit 300 on cart 15. Pump 310 controls the pressure of the fluid delivered along inflow line 30 to hysteroscope 100. System 10 also includes a gravity container 40 on cart 15 connected by an outflow line 32 to an outflow valve 105 on hysteroscope 100 to collect the outflow of fluid from hysteroscope 100, under the force of gravity. In addition, system 10 includes a surgical drape 22 connected by outflow line 32 to gravity container 40 to collect fluid from patient 20.


System 10 further includes a resector 200 that is received within hysteroscope 100 during use to resect tissue from the organ. Resector 200 includes a handle 205 and a distal portion 210 that extends out of distal portion 102 of hysteroscope 100. Distal portion 210 includes a working end 220, e.g., a morcellator, that can be actuated to cut tissue from the organ. Handle 205 includes a motor (not shown) coupled to working end 220 to rotate working end 220 about a longitudinal axis to cut tissue. Also located on cart 15 is a resector control unit 60 of system 10 connected by a wire 201 to resector 200 to control movement of working end 220. System 10 also includes a footpedal 62 connected to control unit 60 by a wire 64 to actuate control unit 60.


Also located on cart 15 are four vacuum containers 42 of system 10 connected by suction line 34 to a suction port 230 on resector 200 to collect fluid and tissue suctioned through resector 200. At least one of vacuum containers 42 includes a tissue trap 43 that collects tissue suctioned through suction lines 34 for later examination, e.g., by a pathologist. System 10 also includes a vacuum regulator 400 connected by a suction line 36 to vacuum containers 42 and by vacuum line 38 to a vacuum source (not shown) to regulate suction provided by the vacuum source through suction channel 204 of resector 200.


Also located on cart 15 is a fluid monitoring unit 18 of system 10 that tracks the amount of fluid collected in gravity container 40 and vacuum containers 42 and the amount of fluid pumped by fluid management control unit 300 and sets off an audible or visual alarm if the difference between the amounts of fluid pumped and collected is above a threshold value, thus minimizing the possibility of excess fluid intravasation.


Part of system 10 is a visualizing and imaging assembly 50 that includes a camera 51 coupled to a camera port 106 of hysteroscope 100, and a light source 52 coupled by a fiber optic cable 54 to a light port 109 of hysteroscope 100. Together, camera 50 and light source 52 allow a user to remotely visualize the tissue at distal end 102 of hysteroscope 100. Assembly 50 also includes an imaging station 70 connected by a fiber optic cable 56 to camera 50. Imaging station 70 has monitors 72 for viewing images from camera 50 and a capture system 74 for making a recording of the images.


Referring to FIGS. 2A and 2B, hysteroscope 100 includes a sheath 80 that has a tube 120 with an inner wall 122 defining a channel 121 therethrough. Distal end 102 of tube 120 includes a plurality of holes 112 in communication with channel 121 for allowing fluid to flow out of an organ through channel 121. Sheath 80 has a proximal portion 84 that includes outflow port 105. Outflow port 105 is in fluid communication with channel 121. Positioned between outflow port 105 and channel 121 is an on/off valve 123 for turning on and off fluid flow from channel 121 to outflow port 105.


Hysteroscope 100 also includes a scope housing 90 that has an elongated member 124 removably receivable in tube 120. Member 124 has an outer wall 126 and an inner wall 125. Inner wall 125 that defines an inflow channel 130. A proximal portion 94 of scope housing 90 includes inflow port 110, a primary valve 150, and a secondary valve 160, which are fluidly connected to inflow channel 130, as described below. Member 124 also defines a lens channel 140 that houses an optical lens 142. Scope housing 90 has a proximal portion 94 that includes camera port 106 and light port 109, which are coupled to optical lens 142 by fiber optic lines (not shown). Light travels from light port 109 to distal end 102 of hysteroscope 100 to illuminate objects near distal end 102. Images of those objects are received by optical lens 142, and travel through camera port 106 to camera (FIG. 1), to allow the user to view the organ through hysteroscope 100. Lens channel 140 is positioned adjacent to inflow channel 130 to help keep optical lens 142 clear of debris during use. Proximal portion 94 of scope housing 90 also includes a pin 92 receivable in a J-shaped slot (not shown) in sheath 80 to releasably lock scope housing 90 to sheath 80 when member 124 is received in tube 120.


Referring also to FIGS. 3A and 3B, when member 124 is received in tube 120, inner wall 122 of tube 120 and outer wall 126 of member 124 define a passive outflow channel 128 therebetween. Passive outflow channel 128 is divided into a left portion 128A and a right portion 128B, which reconnect at outflow port 105. Passive outflow channel 128 is in fluid communication with holes 112 in distal end 102 of tube 120 and with outflow port 105 to permit passive outflow of fluid from the organ under the force of gravity. It will be understood that outflow channel 128 need not be divided. Inner wall 125 of member 124 defines inflow channel 130 that is in fluid communication with an aperture 108 in distal end 102 of hysteroscope 100 to permit fluid flow into the organ. Fluid flows through passive outflow channel 128 along a path that is completely separate from a path along which fluid flows through inflow channel 130.


Referring to FIG. 3B, inflow channel 130 and passive outflow channel 128 are sized and configured so that fluid management control unit 300, which has an inflow rate of up to 0.7 L/min, is able to maintain a substantially constant fluid pressure inside a distensible organ by pumping sufficient fluid into the organ through inflow channel 130 to balance fluid flow out of the organ through passive outflow channel 128, as described below. For example, inflow channel 130 has a D-shaped cross-section with a cross-sectional area, e.g., of about 0.0153 to about 0.0461 square inches, preferably about 0.0307 square inches, and each portion 128A, 128B of passive outflow channel 128 has a crescent-shaped cross-section with a combined cross-sectional area, e.g., of about 0.0083 to about 0.0249 square inches, preferably about 0.0166 square inches. It should be understood that other configurations and sizes of inflow channel 130 and passive outflow channel 128 are possible, so long as outflow of fluid through outflow channel 128 does not exceed the ability of fluid management control unit 300 to pump fluid into the organ through inflow channel 130 at least at the same flow rate as the outflow of fluid.


Referring to FIGS. 4 and 5, resector 200 includes a stationary elongated outer tube 202 and a rotatable inner tube 201 that is coupled to working end 220 (not shown). Inflow channel 130 receives resector 200 therethrough. The cross-section of inflow channel 130 enables inflow channel 130 to be only partially blocked by resector 200, allowing fluid to continue to flow into the organ through a region of inflow channel 130 unblocked by resector 200, located between inner wall 125 and elongated tube 202. Inner tube 201 of resector 200 defines a suction channel 204 having an opening 206 at working end 220 of resector 200 and in fluid communication with suction port 230 of resector handle 205 (FIG. 1) to permit suction of fluid and tissue from the organ. Fluid is suctioned through suction channel 204 along a path that is completely separate from the paths along which fluid flows through outflow channel 128 and inflow channel 130.


Referring to FIG. 5, passive outflow channel 128, inflow channel 130, and suction channel 204 are sized and configured so that fluid management control unit 300 is able to maintain the substantially constant fluid pressure inside the organ by pumping sufficient fluid into the organ to balance fluid flow out of the organ through passive outflow channel 128 and suction of fluid out of the organ through suction channel 204, as described below. For example, the portion of inflow channel 130 not blocked by resector 200 has a cross-sectional area of about 0.0106 square inches, passive outflow channel 128 has a cross-sectional area of about 0.0166 square inches, and suction channel 204 has a cross-sectional area of about 0.0085 square inches. It should be understood that other configurations and sizes of inflow channel 130, passive outflow channel 128, and suction channel 204 are possible, so long as outflow of fluid through outflow channel 128 and suction of fluid through suction channel 204 do not exceed the ability of fluid management control unit 300 to pump fluid into the organ through inflow channel 130 at the same flow rate as the outflow of fluid.


The ability of fluid management control unit 300 to maintain a substantially constant fluid pressure in the organ is further facilitated by secondary valve 160 of scope housing 90, which maintains substantially the same fluid flow impedance through inflow channel 130 regardless of whether resector 200 is positioned in scope housing 90. For example, FIG. 14 shows the impedance through hysteroscope 100 at various flow rates, regardless of whether resector 200 is positioned in scope housing 90. By maintaining a substantially constant fluid flow impedance, secondary valve 160 facilitates fluid management control unit maintaining a substantially constant pressure in the organ regardless of whether resector 200 is positioned in scope housing 90. Impedance refers to the pressure drop in fluid between two points (in this case between inflow port 110 and the distal end of inflow channel 130) and varies proportional to the square of the flow rate.


Referring to FIGS. 6A and 6B, secondary valve 160 has a housing 162 and a body 164 rotatable within housing 162. Housing 162 includes an inlet 167 aligned with inflow port 110 and an outlet 169 aligned with inflow channel 130. Body 164 defines a throughbore 166 and a smaller diameter blind bore 168 having an open end 168A and a closed end 168B. Blind bore 168 intersects throughbore 166 substantially orthogonal to throughbore 166 and has a diameter substantially equal to the diameter of intermediate channel 155.


Body 164 is attached to a handle 165 that allows body 164 to be moveable between a first position (FIGS. 6A-6B) defining a first fluid flow path A and a second position (FIGS. 7A-7B) defining a second fluid flow path B. When secondary valve 160 is in the first position, blind bore 168 is aligned with outlet 169 and throughbore 166 is parallel to, but offset from, inlet 167 such that body 164 partially blocks inlet 167. Fluid flow along path A is impeded by body 164 partially blocking inlet 167.


Referring to FIGS. 7A and 7B, when secondary valve 160 is in the second position, blind bore 168 is aligned with inlet 167 and throughbore 166 is aligned with outlet 169 such that fluid can flow through secondary valve 160 along path B. In use, with secondary valve 160 in the second position, resector 200 is received through throughbore 166 of secondary valve 160, such that resector 200 is received within inflow channel 130 of hysteroscope 130. Fluid flow along path B is impeded by resector 200 partially blocking throughbore 166 and inflow channel 130. The impedance of fluid flow along path B due to resector 200 blocking fluid flow is substantially equal to the impedance of fluid flow along path A due to body 164 blocking fluid flow. Thus, secondary valve 160 allows for substantially the same impedance of fluid flow through inflow channel 130 and into the organ regardless of whether resector 200 is received through hysteroscope 100.


Referring also to FIGS. 8A and 8B, a primary valve 150 is positioned between inflow port 110 and secondary valve 160 to provide on/off control of fluid flow from inflow port 110 through secondary valve 160 into inflow channel 130. Primary valve 150 includes a housing 152 and a body 154 rotatable within housing 152 and defining a throughbore 156. Body 154 is connected to a handle 153 for moving body 154 between a fully opened position (FIGS. 6A and 6B), wherein throughbore 156 is aligned with inflow port 110 to allow fluid to flow to inflow channel 130, and a fully closed position (FIGS. 8A and 8B), where fluid flow to inflow channel 130 is blocked. Primary valve 150 and secondary valve 160 are removably connected to a proximal end 107 of hysteroscope 100 by a threaded portion 161 having a bore 163 therethrough that is aligned with inflow channel 130.


Fluid management control unit 300 maintains a substantially constant fluid pressure inside the organ by pumping sufficient fluid into the organ through inflow channel 130 to balance fluid flow out of the organ through passive outflow channel 128 and from suction of fluid through suction channel 204 (when resector 200 is received in hysteroscope 100). Referring to FIG. 9, fluid management control unit 300 includes peristaltic pump 310 through which runs fluid line 30 that transmits fluid from fluid bag 17 to inflow port 110 of hysteroscope 100. Pump 310 pumps fluid along fluid line 310, controlling the pressure and flow rate of fluid transmitted to hysteroscope 100.


Fluid management control unit 300 includes a flow rate sensor 315, such as a roller head, a turbine, or an ultrasonic sensor, that measures the flow rate of fluid outputted by pump 310. Control unit 300 also includes a pressure sensor, e.g., pressure transducer 320, that senses the fluid pressure in fluid line 30 after the fluid passes through pump 310. Fluid management control unit 300 also includes an input 345 where a user can input a desired pressure to be maintained inside the organ, and a memory 340 that contains information on the impedance (i.e., pressure drop) through the hysteroscope 100 and resector 200 combination at a range of different flow rates.


Coupled to pressure sensor 320, pump 310, flow rate sensor 315, input 345, and memory 340, is a controller 330, e.g., a microprocessor, that controls the pressure and the flow rate outputted by pump 310 based on the flow rate measured by flow rate sensor 315, the pressure measured by pressure sensor 320, the information stored in memory 340, and the target pressure 345. Based on a measured flow rate and a measured pressure, controller 330 determines the actual pressure in the organ according to the information stored in memory 340 that accounts for the impedance (i.e., pressure drop) through the hysteroscope 100 at various flow rates. Controller 330 then compares the pressure in the organ with the target pressure and adjusts the pressure and flow rate outputted by pump 310 accordingly. If the target pressure is greater than the actual pressure, then controller 330 increases the output of pump 310. If the target pressure is less than the actual pressure, then controller 330 decreases the output of pump 310.


The size and configuration of inflow channel 130, passive outflow channel 128, and suction channel 204 facilitate controller 330 maintaining substantially constant pressure in the organ. In addition, secondary valve 160 facilitates maintaining a substantially constant pressure in the organ by keeping the impedance through hysteroscope 100 the same regardless of whether resector 200 is received in hysteroscope 100. Thus, it is not necessary for controller 330 to “know” whether resector 200 is positioned in hysteroscope 100. Fluid management control unit 300 is able to maintain a relatively constant pressure of fluid within the organ, e.g., at a preset pressure between about 60 mm Hg and about 120 mm Hg.


Fluid management control unit 300 also includes a feature that verifies that a correct combination of hysteroscope 100 and resector 200 is being used (i.e., to ensure that the system is only used when a resector and a hysteroscope having properly balanced flow channels are attached to fluid management control unit 300). Memory 340 contains flow rate and impedance information for each valid combination of a hysteroscope and a resector. Controller 330 is programmed to determine whether the pressure measured by pressure transducer 320 is within a threshold value of a predetermined pressure for a given flow rate in order to verify the identity of the combination of the hysteroscope and the resector. Controller 330 is coupled to a shut-off circuit 360 to disable pump 310 when controller 330 determines that the combination of hysteroscope and resector is invalid (e.g., when an incorrect size resector is used with the hysteroscope). If the combination is verified, then controller 330 overrides shut-off circuit 360 and allows pump 310 to pump fluid to hysteroscope 100, as described above. On the other hand, if controller 330 determines that the combination of the hysteroscope and the resector is invalid (e.g., wrong size resector), the controller 330 activates shut-off circuit 360 to disable pump 310. Controller 330 also is coupled to an alarm 350, e.g., a visual or audible alarm, that is activated when pump 310 is disabled. Controller 330 is programmed to make pressure comparisons at several (e.g., three or four) flow rates prior to use of hysteroscope 100 and resector 200.


In use, a user assembles the components of resection system 10 as shown in FIG. 1. As shown in FIGS. 7A and 7B, the user positions primary valve 150 in the open position and secondary valve 160 in the second position. The user inserts resector 200 through hysteroscope 100. The user verifies the combination of hysteroscope 100 and resector 200 by activating fluid management control unit 300, as described above with respect to FIG. 9, to infuse fluid through hysteroscope 100 and resector 200 assembly at three or four different flow rates, to sense the flow impedance through the assembly, and to compare each sensed flow impedance to predetermined flow impedances. If the combination is verified, the user removes resector 200 from hysteroscope 100, closes primary valve 150, and moves secondary valve 160 to the first position, as shown in FIGS. 8A and 8B.


Referring to FIG. 10, to position sheath 80 within the uterus, system 10 includes an obturator 800 insertable through sheath 80 when scope housing 90 is removed from sheath 80. Obturator 800 includes a shaft 810, a sharp, distal tip 820, and a proximal handle 840. Disposed between handle 840 and shaft 810 is a pin 830 that fits into the J-shaped slot (not shown) in sheath 80 to removably lock obturator 800 to sheath 80.


Referring to FIG. 11, with obturator 800 received within sheath 80 such that tip 820 extends beyond distal portion 102 of sheath 80, the user inserts obturator 800 and sheath 80 into a uterus 900. Referring to FIG. 12, the user removes obturator 800 from sheath 80, and inserts scope housing 90 through sheath 80 and into uterus 900. The user then opens primary valve 150 while leaving secondary valve 160 in the first position, as shown in FIGS. 6A and 6B, and activates fluid management control system 300 to pump fluid through channel 130 of hysteroscope 100 and into uterus 900 along flow path A, at a first impedance, to distend uterus 900, as shown in FIG. 12. At the same time, the user allows fluid to flow out of uterus 900 via holes 112 and channel 122 in hysteroscope 100 along flow path C to gravity container 40, in order to keep the pressure inside uterus 900 between about 60 mm Hg and 120 mm Hg.


Once uterus 900 has been distended, with primary valve 150 still open, the user positions secondary valve 160 in the second position, as shown in FIGS. 7A and 7B, and inserts resector 200 through secondary valve 160 and inflow channel 130 of hysteroscope 100, and into uterus 900, as shown in FIG. 13. Fluid management control system 300 continues to pump fluid so that fluid flows through inflow channel 130, between inner wall 125 and resector 200 and into uterus 900 at a second impedance substantially equal to the first impedance. At the same time, the user allows fluid to flow out of uterus 900 via holes 112 and channel 128 in hysteroscope along flow path C and suctions fluid out of uterus 900 through resector 200 along flow path D, in order to keep the pressure inside uterus 900 between about 60 mm Hg and 120 mm Hg. Fluid suctioned along path D is collected in vacuum containers 42. The user also can actuate vacuum regulator 400 to control the amount of suction through resector 200 along path D. Preferably, the user maintains the vacuum pressure above approximately 100 mm Hg (to facilitate tissue removal) and below approximately 200 mm Hg (to inhibit uterus collapse). In order to inhibit uterus collapse, vacuum regulator 400 is preset to not allow vacuum pressure greater than a threshold value, e.g., 200 mm Hg, to be applied.


The user visualizes the inside of uterus 900 on monitors 62 of visualizing and imaging assembly 50. The user actuates foot pedal 62, which activates resector control unit 60. Resector control unit 60 activates resector 200, e.g., by rotating a cutting blade 910 at working end 220 of resector 200, to cut tissue from uterus 900. Fluid and tissue cut by blade 910 are suctioned through channel 204 of resector 200 along path D. During the procedure, resector 200 can be removed from hysteroscope 100 while hysteroscope 100 remains inside uterus 900, e.g., to clean resector 200 or change instruments, so long as the user moves secondary valve 160 to the closed position, as shown in FIGS. 6A and 6B, while removing resector 200 to permit greater inflow through channel 130 of hysteroscope 100.


During the procedure fluid monitor unit 18 tracks the amount of fluid infused through resector 200 and the amount of fluid collected in gravity container 40 and vacuum containers 42. Fluid monitor unit 18 sets off an audible or a visual alarm if substantially more fluid is infused than collected, which indicates that the patient is absorbing too much fluid. Once the procedure is complete, the user closes primary valve 150, as shown in FIGS. 8A and 8B, and removes resector 200 and hysteroscope 100 from uterus 900.


A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. For example, the shape, size, and configuration of the fluid flow channels through the hysteroscope and the resector could be different than that shown and described, such as having an inflow channel with an elliptical, square, triangular, or trapezoidal cross-section. Instead of a blind bore, the body of the secondary valve could include a peripheral channel formed in an outer surface of the body. Instead of a secondary valve, the primary valve could be electronically controlled to maintain a constant impedance through the hysteroscope regardless of whether the resector is inserted through the hysteroscope. The hysteroscope can be used with other types of resector tools having rotatable working ends, such as burrs or drills. The hysteroscope also can be used with a resector tool having a reciprocating working end, such as the instrument disclosed in U.S. patent application Ser. No. 10/318,400 entitled “Reciprocating rotary arthroscopic surgical instrument,” the entirety of which is incorporated herein by reference. The fluid management system can include another type of pump, such as a centrifugal, piston, or diaphragm pump. The vacuum regulator could include a manually or electronically operable valve, a flow sensor, and/or a pressure gauge. The devices shown can be used for surgery on other distensible organs, such as a shoulder or knee joint. Different combinations of the components of the system could be used or components could be added or deleted. These and other embodiments are within the scope of the following claims.

Claims
  • 1. A tissue resecting system comprising: a first medical instrument configured to be inserted into a distensible organ to flow fluid into and out of the distensible organ, the first medical instrument having an inflow channel for flowing the fluid into the distensible organ; a second medical instrument configured to be received within the inflow channel of the first medical instrument; and a fluid management control unit configured to supply the fluid to the first medical instrument through an inflow line, the fluid management control unit including: a pump configured to pump the fluid to the first medical instrument through the inflow line; a flow rate sensor configured to measure a fluid flow rate within the inflow line; a pressure sensor configured to measure a fluid pressure within the inflow line; memory storing information; and a controller configured to control the pump based on (i) the measured fluid flow rate within the inflow line, (ii) the measured fluid pressure within the inflow line, and (iii) the information, the controller being further configured to verify the first medical instrument and the second medical instrument as one of a plurality of valid medical instrument combinations based on the measured fluid flow rate and the measured fluid pressure.
  • 2. The system of claim 1, wherein the information includes fluid flow rates and predetermined fluid pressures at the fluid flow rates for the plurality of valid medical instrument combinations.
  • 3. The system of claim 1, wherein the controller is configured to verify the first medical instrument and the second medical instrument as one of the plurality of valid medical instrument combinations based on the measured fluid pressure satisfying a threshold associated with the measured fluid flow rate, with the second medical instrument received within the inflow channel of the first medical instrument.
  • 4. The system of claim 3, wherein the threshold is based on a predetermined fluid pressure at the measured fluid flow rate.
  • 5. The system of claim 3, wherein the controller is further configured to verify the first medical instrument and the second medical instrument as one of the plurality of valid medical instrument combinations based on measured fluid pressures within the inflow channel satisfying respective thresholds for measured fluid flow rates with the second medical instrument received within the inflow channel of the first medical instrument.
  • 6. The system of claim 1, further comprising: an interface configured to accept one or more user inputs to set a desired fluid pressure within the distensible organ,wherein, based on the desired fluid pressure, the controller is configured to control the pump to achieve a fluid flow rate corresponding to the desired fluid pressure.
  • 7. The system of claim 1, wherein the first medical instrument is one of a plurality of first medical instruments, the second medical instrument is one of a plurality of second medical instruments, and the information includes combinations of the first medical instruments and the second medical instruments as the plurality of valid medical instrument combinations, with fluid flow rates and corresponding fluid pressures for each of the plurality of valid medical instrument combinations.
  • 8. The system of claim 1, wherein the first medical instrument and the second medical instrument being one of the plurality of valid medical instrument combinations is based on fluid flow into the distensible organ with the second medical instrument not received within the inflow channel of the first medical instrument being substantially equal to fluid flow into the distensible organ with the second medical instrument received within the inflow channel of the first medical instrument.
  • 9. The system of claim 1, wherein the controller is further configured to disable the pump upon a determination that the first medical instrument and the second medical instrument is an invalid combination.
  • 10. The system if claim 9, wherein the fluid management control unit further includes an alarm that is configured to provide an audible indication and/or a visual indication in response to the determination when the controller disables the pump.
  • 11. The system of claim 1, wherein the fluid management control unit further includes a shut-off circuit configured to shut-off the pump, and the controller is further configured to override the shut-off circuit upon verifying the first medical instrument and the second medical instrument as one of the plurality of valid medical instrument combinations.
  • 12. The system of claim 1, wherein the first medical instrument is a hysteroscope.
  • 13. The system of claim 12, wherein the second medical instrument is a resector.
  • 14. The system of claim 13, wherein the distensible organ is a uterus.
  • 15. The system of claim 1, wherein the controller is configured to control the pump to maintain a pressure in the distensible organ between about 60 mmHg and about 120 mmHg.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of prior application Ser. No. 14/811,331, filed Jul. 28, 2015, which is a division of prior application Ser. No. 14/473,389, filed Aug. 29, 2014, now U.S. Pat. No. 9,125,550, which is a continuation of prior application Ser. No. 13/860,654, filed Apr. 11, 2013, now U.S. Pat. No. 8,852,085, which is a continuation of prior application Ser. No. 13/212,240, filed Aug. 18, 2011, now U.S. Pat. No. 8,419,626, which is a continuation of prior application Ser. No. 10/927,244, filed Aug. 27, 2004, now U.S. Pat. No. 8,062,214, each of which is hereby incorporated by reference herein in its entirety.

US Referenced Citations (288)
Number Name Date Kind
1585934 Muir May 1926 A
1666332 Hirsch Apr 1928 A
1831786 Duncan Nov 1931 A
2708437 Hutchins May 1955 A
3297022 Wallace Jan 1967 A
3686706 Finley Aug 1972 A
3734099 Bender May 1973 A
3791379 Storz Feb 1974 A
3812855 Banko May 1974 A
3835842 Iglesias Sep 1974 A
3850162 Iglesias Nov 1974 A
3945375 Banko Mar 1976 A
3980252 Tae Sep 1976 A
3995619 Glatzer Dec 1976 A
3996921 Neuwirth Dec 1976 A
4011869 Seiler, Jr. Mar 1977 A
4108182 Hartman Aug 1978 A
4146405 Timmer Mar 1979 A
4198958 Utsugi Apr 1980 A
4203444 Bonnell May 1980 A
4210146 Banko Jul 1980 A
4246902 Martinez Jan 1981 A
4247180 Norris Jan 1981 A
4258721 Parent Mar 1981 A
4261346 Wettermann Apr 1981 A
4294234 Matsuo Oct 1981 A
4316465 Dotson, Jr. Feb 1982 A
4369768 Vukovic Jan 1983 A
4392485 Hiltebrandt Jul 1983 A
4414962 Carson Nov 1983 A
4449538 Corbitt May 1984 A
4493698 Wang Jan 1985 A
4517977 Frost May 1985 A
4543965 Pack Oct 1985 A
4567880 Goodman Feb 1986 A
4589414 Yoshida May 1986 A
4601284 Arakawa Jul 1986 A
4601290 Effron Jul 1986 A
4606330 Bonnet Aug 1986 A
4630598 Bonnet Dec 1986 A
4644952 Patipa Feb 1987 A
4649919 Thimsen Mar 1987 A
4700694 Shishido Oct 1987 A
4706656 Kuboto Nov 1987 A
4718291 Wood Jan 1988 A
4737142 Heckele Apr 1988 A
4749376 Kensey Jun 1988 A
4756309 Sachse Jul 1988 A
4819635 Shapiro Apr 1989 A
4844064 Thimsen Jul 1989 A
4850354 McGurk-Burleson Jul 1989 A
4856919 Takeuchi Aug 1989 A
4867157 McGurk-Burleson Sep 1989 A
4924851 Ognier May 1990 A
4940061 Terwilliger Jul 1990 A
4950278 Sachse Aug 1990 A
4955882 Hakky Sep 1990 A
4971034 Doi Nov 1990 A
4986827 Akkas Jan 1991 A
4998527 Meyer Mar 1991 A
4998914 Wiest Mar 1991 A
5007917 Evans Apr 1991 A
5027792 Meyer Jul 1991 A
5037386 Marcus Aug 1991 A
5105800 Takahashi Apr 1992 A
5106364 Hayafuji Apr 1992 A
5112299 Pascaloff May 1992 A
5116868 Chen May 1992 A
5125910 Freitas Jun 1992 A
5133713 Huang Jul 1992 A
5152744 Krause Oct 1992 A
5158553 Berry Oct 1992 A
5163433 Kagawa Nov 1992 A
5169397 Sakashita Dec 1992 A
5176677 Wuchinich Jan 1993 A
5195541 Obenchain Mar 1993 A
5226910 Kajiyama Jul 1993 A
5244459 Hill Sep 1993 A
5254117 Rigby Oct 1993 A
5269785 Bonutti Dec 1993 A
5270622 Krause Dec 1993 A
5275609 Pingleton Jan 1994 A
5288290 Brody Feb 1994 A
5304118 Trese Apr 1994 A
5312399 Hakky May 1994 A
5312425 Evans May 1994 A
5312430 Rosenbluth May 1994 A
5320091 Grossi Jun 1994 A
5347992 Pearlman Sep 1994 A
5350390 Sher Sep 1994 A
5364395 West, Jr. Nov 1994 A
5374253 Burns, Sr. Dec 1994 A
5390585 Ryuh Feb 1995 A
5392765 Muller Feb 1995 A
5395313 Naves Mar 1995 A
5403276 Schechter Apr 1995 A
5409013 Clement Apr 1995 A
5409453 Lundquist Apr 1995 A
5411513 Ireland May 1995 A
5421819 Edwards Jun 1995 A
5425376 Banys Jun 1995 A
5429601 Conley Jul 1995 A
5435805 Edwards Jul 1995 A
5443476 Shapiro Aug 1995 A
5449356 Walbrink Sep 1995 A
5456673 Ziegler Oct 1995 A
5456689 Kresch Oct 1995 A
5483951 Frassica Jan 1996 A
5490819 Nicholas Feb 1996 A
5490860 Middle Feb 1996 A
5492537 Vancaillie Feb 1996 A
5498258 Hakky Mar 1996 A
5527331 Kresch Jun 1996 A
5549541 Muller Aug 1996 A
5556378 Storz Sep 1996 A
5563481 Krause Oct 1996 A
5569164 Lurz Oct 1996 A
5569254 Carlson Oct 1996 A
5569284 Young Oct 1996 A
5575756 Karasawa Nov 1996 A
5586973 Lemaire Dec 1996 A
5591187 Dekel Jan 1997 A
5601583 Donahue Feb 1997 A
5601603 Illi Feb 1997 A
5602449 Krause Feb 1997 A
5603332 O'Connor Feb 1997 A
5630798 Beiser May 1997 A
5649547 Ritchart Jul 1997 A
5669927 Boebel Sep 1997 A
5672945 Krause Sep 1997 A
5674179 Bonnet Oct 1997 A
5676497 Kim Oct 1997 A
5695448 Kimura Dec 1997 A
5702420 Sterling Dec 1997 A
5709698 Adams Jan 1998 A
5730752 Alden Mar 1998 A
5733298 Berman Mar 1998 A
5741286 Recuset Apr 1998 A
5741287 Alden Apr 1998 A
5749885 Sjostrom May 1998 A
5749889 Bacich May 1998 A
5759185 Grinberg Jun 1998 A
5772634 Atkinson Jun 1998 A
5775333 Burbank Jul 1998 A
5782849 Miller Jul 1998 A
5807240 Muller Sep 1998 A
5807282 Fowler Sep 1998 A
5810770 Chin Sep 1998 A
5810861 Gaber Sep 1998 A
5814009 Wheatman Sep 1998 A
5833643 Ross Nov 1998 A
5840060 Beiser Nov 1998 A
5857995 Thomas Jan 1999 A
5873886 Larsen Feb 1999 A
5899915 Saadat May 1999 A
5911699 Anis Jun 1999 A
5911722 Adler Jun 1999 A
5913867 Dion Jun 1999 A
5916229 Evans Jun 1999 A
5925055 Adrian Jul 1999 A
5928163 Roberts Jul 1999 A
5944668 Vancaillie Aug 1999 A
5947990 Smith Sep 1999 A
5951490 Fowler Sep 1999 A
5956130 Vancaillie Sep 1999 A
5957832 Taylor Sep 1999 A
6001116 Heisler Dec 1999 A
6004320 Casscells Dec 1999 A
6007513 Anis Dec 1999 A
6024751 Lovato Feb 2000 A
6032673 Savage Mar 2000 A
6039748 Savage Mar 2000 A
6042552 Cornier Mar 2000 A
6068641 Varsseveld May 2000 A
6086542 Glowa Jul 2000 A
6090094 Clifford Jul 2000 A
6090123 Culp Jul 2000 A
6113594 Savage Sep 2000 A
6119973 Galloway Sep 2000 A
6120147 Vijfvinkel Sep 2000 A
6120462 Hibner Sep 2000 A
6132448 Perez Oct 2000 A
6149633 Maaskamp Nov 2000 A
6156049 Lovato Dec 2000 A
6159160 Hsei Dec 2000 A
6159209 Hakky Dec 2000 A
6203518 Anis Mar 2001 B1
6217543 Anis Apr 2001 B1
6224603 Marino May 2001 B1
6244228 Kuhn Jun 2001 B1
6258111 Ross Jul 2001 B1
6277096 Cortella Aug 2001 B1
6315714 Akiba Nov 2001 B1
6358200 Grossi Mar 2002 B1
6358263 Mark Mar 2002 B2
6359200 Day Mar 2002 B1
6402701 Kaplan Jun 2002 B1
6428486 Ritchart Aug 2002 B2
6471639 Rudischhauser Oct 2002 B2
6494892 Ireland Dec 2002 B1
6585708 Maaskamp Jul 2003 B1
6610066 Dinger Aug 2003 B2
6626827 Felix Sep 2003 B1
6632182 Treat Oct 2003 B1
6656132 Ouchi Dec 2003 B1
6712773 Viola Mar 2004 B1
6824544 Boebel Nov 2004 B2
6837847 Ewers Jan 2005 B2
7025720 Boebel Apr 2006 B2
7025732 Thompson Apr 2006 B2
7150713 Shener Dec 2006 B2
7226459 Cesarini Jun 2007 B2
7249602 Emanuel Jul 2007 B1
7510563 Cesarini Mar 2009 B2
7763033 Gruber Jul 2010 B2
7922737 Cesarini Apr 2011 B1
8025656 Gruber Sep 2011 B2
8061359 Emanuel Nov 2011 B2
8062214 Shener Nov 2011 B2
8419626 Shener-Irmakoglu Apr 2013 B2
8465421 Finkman Jun 2013 B2
8528563 Gruber Sep 2013 B2
8574253 Gruber Nov 2013 B2
8647349 Gruber Feb 2014 B2
8663264 Cesarini Mar 2014 B2
8678999 Isaacson Mar 2014 B2
8834487 Gruber Sep 2014 B2
8840625 Adams Sep 2014 B2
8840626 Adams Sep 2014 B2
8852085 Shener-Irmakoglu Oct 2014 B2
8893722 Emanuel Nov 2014 B2
8932208 Kendale Jan 2015 B2
8951274 Adams Feb 2015 B2
9060760 Sullivan Jun 2015 B2
9060800 Cesarini Jun 2015 B1
9060801 Cesarini Jun 2015 B1
9066745 Cesarini Jun 2015 B2
9072431 Adams Jul 2015 B2
9089358 Emanuel Jul 2015 B2
9095366 Sullivan Aug 2015 B2
9125550 Shener-Irmakoglu Sep 2015 B2
9155454 Sahney Oct 2015 B2
9259233 Gruber Feb 2016 B2
20010039963 Spear Nov 2001 A1
20010047183 Privitera Nov 2001 A1
20020058859 Brommersma May 2002 A1
20020165427 Yachia Nov 2002 A1
20030050603 Todd Mar 2003 A1
20030050638 Yachia Mar 2003 A1
20030078609 Finlay Apr 2003 A1
20030114875 Sjostrom Jun 2003 A1
20040204671 Stubbs Oct 2004 A1
20050043690 Todd Feb 2005 A1
20050085692 Kiehn Apr 2005 A1
20060036132 Renner Feb 2006 A1
20060047185 Shener Mar 2006 A1
20060241586 Wilk Oct 2006 A1
20080015621 Emanuel Jan 2008 A1
20080058588 Emanuel Mar 2008 A1
20080058842 Emanuel Mar 2008 A1
20080097468 Adams Apr 2008 A1
20080097469 Gruber Apr 2008 A1
20080097470 Gruber Apr 2008 A1
20080097471 Adams Apr 2008 A1
20080135053 Gruber Jun 2008 A1
20080146872 Gruber Jun 2008 A1
20080146873 Adams Jun 2008 A1
20080245371 Gruber Oct 2008 A1
20080249366 Gruber Oct 2008 A1
20080249534 Gruber Oct 2008 A1
20080249553 Gruber Oct 2008 A1
20080262308 Prestezog Oct 2008 A1
20090082628 Kucklick Mar 2009 A1
20090270812 Litscher Oct 2009 A1
20090270895 Churchill Oct 2009 A1
20090270896 Sullivan Oct 2009 A1
20090270897 Adams Oct 2009 A1
20090270898 Chin Oct 2009 A1
20100087798 Adams Apr 2010 A1
20100152647 Shener Jun 2010 A1
20110034943 Churchill Feb 2011 A1
20110077674 Sullivan Mar 2011 A1
20110118544 Adams May 2011 A1
20110166419 Reif Jul 2011 A1
20120067352 Gruber Mar 2012 A1
20120078038 Sahney Mar 2012 A1
20130131452 Kuroda May 2013 A1
20140031834 Germain Jan 2014 A1
Foreign Referenced Citations (71)
Number Date Country
3339322 May 1984 DE
3206381 Jul 1986 DE
3601453 Sep 1986 DE
3615694 Nov 1987 DE
4038398 Jun 1992 DE
4440035 May 1996 DE
19633124 May 1997 DE
19751632 Sep 1999 DE
102006022827 Dec 2006 DE
0310285 Apr 1989 EP
0327410 Aug 1989 EP
0557044 Aug 1993 EP
0582295 Feb 1994 EP
0606531 Jul 1994 EP
0621008 Oct 1994 EP
0806183 May 1997 EP
1681022 Jul 2006 EP
2093353 Sep 1982 GB
2311468 Oct 1997 GB
2001-75416 May 1989 JP
2002 529185 Sep 2002 JP
2002 538889 Nov 2002 JP
2003 245247 Sep 2003 JP
1006944 Mar 1999 NL
WO 198101648 Jun 1981 WO
WO 199211816 Jul 1992 WO
WO 199307821 Apr 1993 WO
WO 199315664 Aug 1993 WO
WO 199426181 Nov 1994 WO
WO 199505777 Mar 1995 WO
WO 199510981 Apr 1995 WO
WO 199510982 Apr 1995 WO
WO 199522935 Aug 1995 WO
WO 199530377 Nov 1995 WO
WO 199611638 Apr 1996 WO
WO 199626676 Sep 1996 WO
WO 199709922 Mar 1997 WO
WO 199717027 May 1997 WO
WO 199719642 Jun 1997 WO
WO 199724071 Jul 1997 WO
WO 199734534 Sep 1997 WO
WO 199735522 Oct 1997 WO
WO 199809569 Mar 1998 WO
WO 199810707 Mar 1998 WO
WO 199846147 Oct 1998 WO
WO 199903407 Jan 1999 WO
WO 199903409 Jan 1999 WO
WO 199907295 Feb 1999 WO
WO 199911184 Mar 1999 WO
WO 199939648 Aug 1999 WO
WO 199944506 Sep 1999 WO
WO 199960935 Dec 1999 WO
WO 200012010 Mar 2000 WO
WO 200028890 May 2000 WO
WO 200033743 Jun 2000 WO
WO 200044295 Aug 2000 WO
WO 200047116 Aug 2000 WO
WO 200057797 Oct 2000 WO
WO 200135831 May 2001 WO
WO 200158368 Aug 2001 WO
WO 200195810 Dec 2001 WO
WO 2002069808 Sep 2002 WO
WO 2003022164 Mar 2003 WO
WO 2003077767 Sep 2003 WO
WO 2005060842 Jul 2005 WO
WO 2005096963 Oct 2005 WO
WO 2006105283 Oct 2006 WO
WO 2006121968 Nov 2006 WO
WO 2006121970 Nov 2006 WO
WO 2007044833 Apr 2007 WO
WO 2012044705 Apr 2012 WO
Non-Patent Literature Citations (128)
Entry
ACMI Corporation, “Dolphin II Hysteroscopic Fluid Management Systems,” ACMI Corporation, 2002 (1 page).
ACMI Corporation, “Dolphin II and Disten-U-Flo Fluid Management Systems for Hysteroscopy”, ACMI Corporation, 2002 (1 page).
Bacsko “Uterine Surgery by Operative Hysteroscopy”, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 71, pp. 219-222, 1997 (4 pages).
Baggish et al., “Diagnostic and Operative Hysterectomy,” Mosby, pp. 97-105, 123-125, 127-132, 353-355, and 394-398, 1999 (27 pages).
C.R. Bard, Inc, “The HydroFlex HD System” (1 page).
Cravello et al., “Hysteroscopic Resection of Fibroids: Results with a 6-Year Follow-up Period”, Journal of Gynecologic Surgery, vol. 15, No. 1, 1-5 1999 (5 pages).
Defendant Hologic Inc.'s Preliminary, Non-Binding List of Asserted Prior Art References, dated Feb. 8, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action Nos. 11-12064-RWZ and 10-10951-RWZ, U.S. District Court for the District of Massachusetts (7 pages).
Dictionary definition of reciprocate, Merrian-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
Dictionary definition of rotate, Merriam-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
Dictionary definition of translate, Merriam-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
Drews et al., “Surgical Approach to Myomas: Laparoscopy and Hysteroscopy”, Seminars in Reproductive Endocrinology, vol. 10, No. 4, pp. 367-377, 1992 (11 pages).
Dumesic et al., “A New Approach to Hysteroscopic Cannulation of the Fallopian Tube”, Journal of Gynecologic Surgery, vol. 7, No. 1, pp. 7-9, 1991 (3 pages).
Emanuel et al., “Long-term Results of Hysteroscopic Myomectomy for Abnormal Uterine Bleeding”, Obstetrics & Gynecoogy, vol. 93, No. 5, Part I, pp. 743-748, 1999 (6 pages).
European Patent Application No. 05 786 521.4-2305, Examination Report dated Apr. 21, 2010 (4 pages).
European Patent Application No. 05 786 521.4-2305, Examination Report dated Sep. 26, 2012 (5 pages).
European Patent Application No. 11 770 261.3-1657, Examination Report dated Feb. 11, 2014 (4 pages).
Exhibit P to Hologic's Opposition to Smith & Nephew's Motion for Preliminary Injunction, Redacted, filed Dec. 30, 2011, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (99 pages).
Franchini et al., “Endometrial resection: a diagnostic tool in postmenopausal women”, Gynecological Endoscopy, 8, pp. 111-114, 1999 (5 pages).
“From Distention to Deficit Monitoring Taking the All-In-One Approach”, W.O.M. World of Medicine (1 page).
Gerber et al., “The Endoscapel: A new endoscopic instrument for supracervical hysterectomy and morcellation of masses; clinical evaluation”, European Journal of Obstetrics & Gynecology and Reproductive Biology, 86, p. S12, 1999 (1 page).
Gynecare “Motor Drive Unit” Instructions for Use (3 pages).
Gynecare X-Tract, “Tissue Morcellator”, Instructions for Use (3 pages).
Gynecare, “Fluid Management System” Instructions for Use (26 pages).
Gynescope Corporation “Laser Fiber Director”, Advertisement, Journal of Gynecologic Surgery, vol. 6, No. 1, 1990 (2 pages).
Hess et al., “Textbook of Bilio-Pancreatic Disease”, vol. III, PICCIN, e.g. Fig 6.5.1, pp. 1584-1586, 1997 (5 pages).
Hologic's Opposition to Smith & Nephew's Motion for Preliminary Injunction, Redacted, filed Dec. 30, 2011, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (26 pages).
“HysteRo-Purator 1143-1 Technical Data” WISAP (2 pages).
International Application No. PCT/US2005/029807, International Preliminary Report on Patentability dated Feb. 28, 2007 (9 pages).
International Application No. PCT/US2005/029807, International Search Report dated Jun. 13, 2006 (5 pages).
International Application No. PCT/US2011/053753, International Preliminary Report on Patentability dated Apr. 2, 2013 (7 pages).
International Application No. PCT/US2011/053753, International Search Report dated Dec. 20, 2011 (4 pages).
Japanese Patent Application No. 2007-530014, Translation of Office Action dated Feb. 15, 2011 (10 pages).
Karl Storz “Pilot a Course to Successful Outcomes”, Intermetro Industries Corporation, 2001 (2 pages).
Karl Storz “Uterine Resectoscopes for Endometrial Ablation and Resection”, Advertisement, Journal of Gynecologic Surgery, vol. 6, No. 1, 1990 (3 pages).
Karl Storz, Advertisement, Journal of Gynecologic Surgery, vol. 5, No. 4, 1989 (3 pages).
Lin et al. “Clinical Applications of a New Fujinon Operating Fiberoptic Hysteroscope”, Journal of Gynecologic Surgery, vol. 6, No. 2, pp. 81-87, 1990 (7 pages).
Mettler et al., “Pelviscopic uterine surgery” Surgical Endoscopy, 6, pp. 23-31, 1992 (9 pages).
Neis et al., “Hysteroscopy: Textbook and Atlas”, Thieme Medical Publishers, pp. 91-103, 1994 (13 pages).
Nisolle et al., “Endometrial ablation with the Nd-YAG laser in dysfunctional bleeding” Minimally Invasive Therapy, vol. 1, pp. 35-39, 1991 (5 pages).
Olympus Product Catalogue: Part No. A2461—OP Nephroscope, Sep. 1991 (3 pages).
Park et al., “Endoscopic Management of Uterine Myoma”, Yonsei Medical Journal, vol. 40, No. 6, pp. 583-588, 1999 (6 pages).
Reexamination No. 95/001,933, Action Closing Prosecution mailed Sep. 19, 2013 (41 pages).
Reexamination No. 95/001,933, Appendices 14-28 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Claim Charts for Various Claims in view of Various References (436 pages).
Reexamination No. 95/001,933, Appendix 2 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Memorandum of Decision dated Apr. 21, 2011, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (14 pages).
Reexamination No. 95/001,933, Appendix 6 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Opening Markman Brief of Plaintiff Smith & Nephew, Inc. dated Oct. 13, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (23 pages).
Reexamination No. 95/001,933, Appendix 7 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Defendant Interlace Medical, Inc's Responsive Markman Brief (Redacted) dated Oct. 27, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (26 pages).
Reexamination No. 95/001,933, Appendix 8 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Plaintiff Smith & Nephew, Inc.'s Reply in Support of Markman Brief dated Nov. 3, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (8 pages).
Reexamination No. 95/001,933, Examiner's Answer dated Mar. 25, 2015 (3 pages).
Reexamination No. 95/001,933, Executed Expert Declaration of Hal Walbrink in support of Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Executed Mar. 9, 2012 (42 pages).
Reexamination No. 95/001,933, First Office Action dated Jun. 5, 2012 (37 pages).
Reexamination No. 95/001,933, Litigation Search Report CRU 3999 dated Mar. 29, 2012 (24 pages).
Reexamination No. 95/001,933, Order Granting Request for Reexamination mailed Jun. 5, 2012 (29 pages).
Reexamination No. 95/001,933, Patent Owner's Apr. 14, 2014 Appeal Brief (334 pages).
Reexamination No. 95/001,933, Patent Owner's Feb. 13, 2014 Notice of Appeal (2 pages).
Reexamination No. 95/001,933, Patent Owner's Aug. 6, 2012 Response to First Office Action dated Jun. 5, 2012 (156 pages).
Reexamination No. 95/001,933, Patent Owner's Jun. 3, 2013 Response to Second Office Action dated Apr. 1, 2013 (37 pages).
Reexamination No. 95/001,933, Patent Owner's Oct. 21, 2013 Response to Action Closing Prosecution mailed Sep. 19, 2013 (180 pages).
Reexamination No. 95/001,933, Right of Appeal Notice mailed Jan. 14, 2014 (58 pages).
Reexamination No. 95/001,933, Second Office Action dated Apr. 1, 2013 (56 pages).
Reexamination No. 95/001,933, Third Party's Dec. 19, 2012 Response to Notification of Defective Paper and Comments on First Office Action dated Jun. 5, 2012 (38 pages).
Reexamination No. 95/001,933, Third Party's Jul. 3, 2013 Comments on Second Office Action dated Apr. 1, 2013 (62 pages).
Reexamination No. 95/001,933, Third Party's Mar. 12, 2012 Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459 (130 pages).
Reexamination No. 95/001,933, Third Party's May 14, 2014 Respondent's Brief (303 pages).
Reexamination No. 95/001,933, Third Party's Nov. 20, 2013 Comments on Action Closing Prosecution mailed Sep. 19, 2013 (38 pages).
Reexamination No. 95/001,933, Third Party's Sep. 5, 2012 Comments on First Office Action dated Jun. 5, 2012 (210 pages).
Reexamination No. 95/001,955, Appendix 19 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Opening Claim Construction Brief of Defendant Hologic, Inc., dated Feb. 24, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (24 pages).
Reexamination No. 95/001,955, Appendix 20 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Opening Markman Brief of Plaintiff Smith & Nephew, Inc., dated Feb. 24, 2012, in Smith & Nephew, Inc.. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (24 pages).
Reexamination No. 95/001,955, Appendix 28 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Pat. No. 5,456,689 to Kresch (4 pages).
Reexamination No. 95/001,955, Appendix 29 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Pat. No. 6,032,673 to Savage (13 pages).
Reexamination No. 95/001,955, Appendix 30 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Pat. No. 3,945,375 to Banko (4 pages).
Reexamination No. 95/001,955, Decision Denying Petition mailed Sep. 28, 2012 (5 pages).
Reexamination No. 95/001,955, Executed Expert Declaration of Dr. Henry A. Dominicis in support of Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Executed Apr. 1, 2012 (150 pages).
Reexamination No. 95/001,955, Executed Expert Declaration of Hal Walbrink in support of Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Executed Apr. 2, 2012 (22 pages).
Reexamination No. 95/001,955, Litigation Search Report CRU 3999 dated Apr. 3, 2012 (33 pages).
Reexamination No. 95/001,955, Order Denying Request for Inter Partes Reexamination mailed Jun. 4, 2012 (35 pages).
Reexamination No. 95/001,955, Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, filed Apr. 2, 2012 (265 pages).
Reexamination No. 95/001,955, Request for Reconsideration of Third Party Requestor's Petition for Reexamination mailed Jul. 3, 2012 (32 pages).
Reexamination No. 95/002,058, Executed Expert Declaration of Dr. Henry A. Dominicis in support of Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Executed Jul. 24, 2012 (101 pages).
Reexamination No. 95/002,058, First Action Closing Prosecution mailed Aug. 9, 2013 (34 pages).
Reexamination No. 95/002,058, First Office Action dated Sep. 19, 2012 (37 pages).
Reexamination No. 95/002,058, Litigation Search Report CRU 3999 dated Aug. 13, 2012 (29 pages).
Reexamination No. 95/002,058, Patent Owner's Mar. 5, 2015 Notice of Appeal (2 pages).
Reexamination No. 95/002,058, Patent Owner's Jan. 22, 2013 Response to First Office Action dated Sep. 19, 2012 (379 pages).
Reexamination No. 95/002,058, Patent Owner's Mar. 24, 2014 Response to Second Office Action dated Jan. 24, 2014 (55 pages).
Reexamination No. 95/002,058, Patent Owner's Sep. 29, 2014 Response to Second Action Closing Prosecution mailed Aug. 27, 2014 (12 pages).
Reexamination No. 95/002,058, Patent Owner's Sep. 9, 2013 Response to First Action Closing Prosecution dated Aug. 9, 2013 (159 pages).
Reexamination No. 95/002,058, Reexam Order mailed Sep. 19, 2012 (54 pages).
Reexamination No. 95/002,058, Right of Appeal Notice mailed Feb. 4, 2015 (35 pages).
Reexamination No. 95/002,058, Second Action Closing Prosecution mailed Aug. 27, 2014 (35 pages).
Reexamination No. 95/002,058, Second Office Action dated Jan. 24, 2014 (31 pages).
Reexamination No. 95/002,058, Third Party's Apr. 23, 2014 Comments on Second Office Action dated Jan. 24, 2014 (117 pages).
Reexamination No. 95/002,058, Third Party's Feb. 21, 2013 Comments on First Office Action dated on Sep. 19, 2012 (771 pages).
Reexamination No. 95/002,058, Third Party's Jul. 24, 2012 Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359 (1050 pages).
Reexamination No. 95/002,058, Third Party's Oct. 19, 2012 Request for Reconsideration of Certain Decisions Regarding Third Party Requestor's Request for Reexamination of U.S. Pat. No. 8,061,359 (19 pages).
Reexamination No. 95/002,058, Third Party's Oct. 29, 2014 Comments on Second Action Closing Prosecution dated Aug. 27, 2014 (31 pages).
Reexamination No. 95/002,058, Third Party's Oct. 9, 2013 Comments on First Action Closing Prosecution dated Aug. 9, 2013 (25 pages).
Reference AQ “Fishing Reel produced and sold by Shimano of Japan in to the U.S. prior to Oct. 26, 2001,” as cited in the IDS filed Oct. 17, 2005 in the prosecution file history of U.S. Appl. No. 09/983,810 (7 pages).
Richard Wolf “‘Morce—Power 2306’ Electronic Morcellator” (2 pages).
Richard Wolf “The Fluid Manager” (2 pages).
Sheth, “Fiberoptic Light for Oophorectomy at Vaginal Hysterectomy”, Journal of Gynecologic Surgery, vol. 14, No. 3, pp. 119-122, 1998 (4 pages).
Sugimoto “A Color Atlas of Hysteroscopy” Springer-Verlag Tokyo, 1999 (17 pages).
U.S. Appl. No. 09/486,977, Office Action dated Sep. 7, 2005 (7 pages).
U.S. Appl. No. 11/780,759, Applicant's Mar. 31, 2011 Response to Office Action dated Jan. 5, 2010 (15 pages).
U.S. Appl. No. 11/780,759, Applicant's Oct. 25, 2010 Response to Office Action dated Jul. 26, 2010 (13 pages).
U.S. Appl. No. 11/780,759, Office Action dated Jan. 5, 2011 (7 pages).
U.S. Appl. No. 11/780,759, Office Action dated Jul. 22, 2010 (5 pages).
U.S. Appl. No. 11/780,759, Office Action dated Jul. 26, 2010 (7 pages).
U.S. Appl. No. 11/929,938, Office Action dated Jan. 5, 2011 (10 pages).
U.S. Appl. No. 11/929,938, Office Action dated Jul. 30, 2010 (10 pages).
U.S. Appl. No. 11/929,940, Advisory Action dated Sep. 10, 2010 (3 pages).
U.S. Appl. No. 11/929,940, Office Action dated Dec. 30, 2009 (9 pages).
U.S. Appl. No. 11/929,940, Office Action dated Jul. 1, 2010 (12 pages).
Valle “Hysteroscopic Removal of Submucous Leiomyomas”, Journal of Gynecologic Surgery, vol. 6, No. 1, pp. 89-96, 1990 (9 pages).
Weck “A Direct Path to Diagnostic and Operative Control: The Weck-Baggish Hysteroscopy System” Advertisement, Journal of Gynecologic Surgery, vol. 7, No. 1, 1991 (2 pages).
Williamson et al., Editorial 1 “Complications of hysteroscopic treatments of menorrhagia”, British Journal of Anesthesia, vol. 77, No. 3, pp. 305-308, 1996 (4 pages).
Reexamination No. 95/002,058, Patent Owner's May 5, 2015 Appeal Brief (47 pages).
Reexamination No. 95/002,058, Third Party's Jun. 5, 2015 Respondent Brief (21 pages).
Reexamination No. 95/002,058, Patent Owner's Jul. 1, 2015 Corrected Appeal Brief (47 pages).
Reexamination No. 95/002,058, Third Party's Jul. 24, 2015 Resubmitted Respondent Brief (21 pages).
Reexamination No. 95/002,058, Examiner's Answer dated Sep. 17, 2015 (3 pages).
Reexamination No. 95/002,058, Patent Owner's Oct. 19, 2015 Rebuttal Brief (25 pages).
Reexamination No. 95/001,933, Patent Owner's Apr. 24, 2015 Rebuttal Brief (8 pages).
Reexamination No. 95/001,933, Patent Trial and Appeal Board's Jan. 20, 2016 Decision on Appeal (35 pages).
Reexamination No. 95/001,933, Patent Owner's Feb. 19, 2016 Request for Rehearing (18 pages).
Reexamination No. 95/001,933, Third Party's Mar. 18, 2016 Opposition to Request for Rehearing (14 pages).
Canadian Patent Application No. 2,578,035, Office Action dated Nov. 21, 2014, 4 pages.
European Patent Application No. 05 786 521.4, Office Action dated Mar. 11, 2015, 4 pages.
European Patent Application No. 05 786 521.4, Office Action dated Apr. 26, 2016, 3 pages.
Related Publications (1)
Number Date Country
20160220102 A1 Aug 2016 US
Divisions (1)
Number Date Country
Parent 14473389 Aug 2014 US
Child 14811331 US
Continuations (4)
Number Date Country
Parent 14811331 Jul 2015 US
Child 15095997 US
Parent 13860654 Apr 2013 US
Child 14473389 US
Parent 13212240 Aug 2011 US
Child 13860654 US
Parent 10927244 Aug 2004 US
Child 13212240 US